Kevin Short

Kevin Short has over 30 years of work experience in the field of medicinal chemistry and drug discovery. Kevin currently holds the position of Director of Medicinal Chemistry at Verseon, a role they have held since December 2021. Prior to joining Verseon, Kevin served as the Director of Discovery Planning at Verseon for over 15 years.

Before their tenure at Verseon, Kevin worked as a Business consultant and representative at Key Organics in 2006. From 2003 to 2005, they were employed at J&J PRD as a Principal Scientist, where they led a team focused on medicinal chemistry projects.

Kevin's earlier experience includes serving as a Principal Scientist at Ontogen from 1995 to 2002. In this role, they were responsible for managing the corporate compound collection and coordinating outsourcing opportunities. Kevin also worked as a Research Scientist at Ontogen Corporation, where they directed multiple chemistry projects involving library design and synthesis.

Kevin's professional journey began at Lederle Laboratories as a Postdoctoral Research Scientist from 1989 to 1991. Overall, Kevin Short's work experience demonstrates their expertise in medicinal chemistry, drug discovery, and project management.

Kevin Short completed their B.Sc. in Chemistry at Imperial College London from 1981 to 1985. Kevin then pursued an M. Phil in Organic Chemistry at the University of Exeter from 1985 to 1987. Afterwards, they obtained a Ph. D in Chemistry from the University of Exeter from 1987 to 1989. Following this, they engaged in postdoctoral studies in Chemistry at Wayne State University from 1991 to 1994. The specific start and end years for their Ph.D. at the University of Exeter and B.Sc. at Imperial College London are not provided.